| Today's Open | $1.15 |
|---|---|
| Previous Close | $1.15 |
| Daily Range | $1.14 - $1.17 |
| 52-Week Range | $1.02 - $5.25 |
| Market Cap | $130.7M |
| P/E Ratio | -0.66 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 356,493 |
| Average Daily Volume | 646,563 |
| Current FY EPS | -$0.61 |
Sector
Healthcare
Industry
Drugs
Cell Therapeutics, Inc. (CTIC) Description
The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer. Website: http://www.celltherapeutics.com/
News & Commentary
Chelsea's Northera might be approvable after all.
The Soft Underbelly of ZIOPHARM Oncology
This stock ought to whet my appetite -- and maybe yours, too.Cell Therapeutics Opens Phase 3 Trial Enrollment for Pacritinib
Study to examine company's myelofibrosis drug pacritinib.CTIC's Top Competitors
(0.87%)
(0.63%)
(1.16%)
(2.44%)